ULIDOVE
LIVE

Serial Number

99401780

Owner

Merck Sharp & Dohme B.V.

Attorney

Palak Mayani

Filing Date

Sep 19, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ULIDOVE Trademark

Serial Number: 99401780 • Registration: 8221773

ULIDOVE is a trademark filed by Merck Sharp & Dohme B.V. on September 19, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Merck Sharp & Dohme B.V. (40 trademarks)

Waarderweg 39
HAARLEM 2031BN , NL

Entity Type: 26

Trademark Details

Filing Date

September 19, 2025

Registration Date

April 21, 2026

Published for Opposition

March 3, 2026

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 21, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 21, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 3, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 3, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 25, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 10, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 9, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 9, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 9, 2026 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 11, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 11, 2025 GNSL
SUSPENSION LETTER WRITTEN
Dec 11, 2025 CNSL
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 11, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 11, 2025 GNSL
SUSPENSION LETTER WRITTEN
Dec 11, 2025 CNSL
ASSIGNED TO EXAMINER
Dec 10, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 19, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 19, 2025 NWOS
NEW APPLICATION ENTERED
Sep 19, 2025 NWAP